New York, New York-- (Newsfile Corp. - January 28, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into TransMedics Group, Inc. (NASDAQ: TMDX) for potential ...
TMDX) suffered a sharp decline over the past two trading days following the release of a damaging report by activist short-seller Scorpion Capital. TransMedics’ stock price has dropped $9.84 ...
TMDX) suffered a sharp decline over the past two trading days following the release of a damaging report by activist short-seller Scorpion Capital. TransMedics' stock price has dropped $9.84 ...
Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of TransMedics Group, Inc. (NASDAQ: TMDX) resulting from ...
Although TMDX refuted Scorpion Capital’s claims as inaccurate and misleading, it raises doubt about its operations in investors’ minds. To receive FDA approval for TMDX’s pre-market approval ...
NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of TransMedics Group, Inc. ("TransMedics" or the "Company") (NASDAQ:TMDX). Such ...
Zacks.com on MSN5d
TMDX Stock Plunges 49.2% in Three Months: What's Behind the Downfall?TransMedics Group, Inc. TMDX investors are continuing to encounter losses from the stock of late. Shares of the Andover, MA-based commercial-stage medical technology company providing organ transplant ...
On January 10, 2025, Scorpion Capital issued a report about the Company alleging fraud, organ trafficking, and off-label device misuse. It stated that in “20 years of shorting, TransMedics is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback